Treatment
-
Forward Look
First Biosimilar Drug Approved in U.S.New drugs will offer same effectiveness, but at a lower cost.
by Stephen Ornes
-
The DCIS Dilemma
Ductal carcinoma in situ is the fourth most common cancer diagnosis in women. Some say it's not "really" cancer. But you wouldn't know that based on how it is treated.
by Sue Rochman
-
Preserving the Future
Young adults undergoing cancer treatment who may want to have children should talk with their doctors about ways to preserve their fertility.
by Marci A. Landsmann
-
From the Editor-in-Chief
The Promise of Precision MedicineThe impact of gene sequencing on the discovery and development of cancer treatments could be profound.
by William G. Nelson, MD, PhD
-
A Dose of Precision
Stereotactic radiation therapy–heavily marketed to consumers–is gaining momentum as a more convenient treatment. But it's not for every patient.
by Sharon Reynolds
-
Forward Look
National Clinical Trials Network Now UnderwayRevamped program aims to get new treatments to patients faster.
by Michael Eisenstein
-
Forward Look
Personalizing Prostate Cancer TreatmentActive surveillance may not be right for all African-American men with low-grade prostate cancer.
by Stephen Ornes
-
Lighting a Fire Under Tobacco-Related Cancers
As researchers unravel the extent and scientific underpinnings of tobacco-related cancers and addiction, patients can seek support to quit tobacco or cope with the stigma often associated with these cancers.
by Stephen Ornes
-
Telling Cancer’s Story
A Pulitzer Prize-winning book about cancer becomes a documentary after noted filmmaker Ken Burns signs on.
by Marilyn Fenichel
-
When Age Is Only a Number
More than half of cancer patients are over 65, but not all older cancer patients should be treated alike. That's where geriatric oncology comes in.
by Yasmine Iqbal